Dr. Sally Arai, MD
Claim this profileStanford University
Studies Lymphoblastic Leukemia-Lymphoma
Studies Acute Lymphoblastic Leukemia
8 reported clinical trials
23 drugs studied
Area of expertise
1Lymphoblastic Leukemia-Lymphoma
HLA-A negative
HLA-A positive
HLA positive
2Acute Lymphoblastic Leukemia
HLA-A negative
HLA-A positive
HLA positive
Affiliated Hospitals
Clinical Trials Sally Arai, MD is currently running
Stem Cell Transplantation
for Leukemia
This is a prospective, multi-center, Phase II study of hematopoietic cell transplantation (HCT) using human leukocyte antigen (HLA)-mismatched unrelated donors (MMUD) for peripheral blood stem cell transplant in adults and bone marrow stem cell transplant in children. Post-transplant cyclophosphamide (PTCy), tacrolimus and mycophenolate mofetil (MMF) will be used for for graft versus host disease (GVHD) prophylaxis. This trial will study how well this treatment works in patients with hematologic malignancies.
Recruiting1 award Phase 2
Axicabtagene Ciloleucel
for Non-Hodgkin Lymphoma
This is a phase Ib study to establish safety of Axi-Cel-2 in patients with Large B Cell Lymphoma (LBCL) who are at high risk of relapse.
Recruiting1 award Phase 1
More about Sally Arai, MD
Clinical Trial Related2 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Sally Arai, MD has experience with
- Cyclophosphamide
- Fludarabine
- Tacrolimus
- Mycophenolate Mofetil
- Total-body Irradiation
- Donor Search Prognosis Score
Breakdown of trials Sally Arai, MD has run
Lymphoblastic Leukemia-Lymphoma
Acute Lymphoblastic Leukemia
Lymphoma
Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sally Arai, MD specialize in?
Sally Arai, MD focuses on Lymphoblastic Leukemia-Lymphoma and Acute Lymphoblastic Leukemia. In particular, much of their work with Lymphoblastic Leukemia-Lymphoma has involved HLA-A negative patients, or patients who are HLA-A positive.
Is Sally Arai, MD currently recruiting for clinical trials?
Yes, Sally Arai, MD is currently recruiting for 4 clinical trials in Stanford California. If you're interested in participating, you should apply.
Are there any treatments that Sally Arai, MD has studied deeply?
Yes, Sally Arai, MD has studied treatments such as Cyclophosphamide, Fludarabine, Tacrolimus.
What is the best way to schedule an appointment with Sally Arai, MD?
Apply for one of the trials that Sally Arai, MD is conducting.
What is the office address of Sally Arai, MD?
The office of Sally Arai, MD is located at: Stanford University, Stanford, California 94305 United States. This is the address for their practice at the Stanford University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.